Recent News Releases
This section includes a wide variety of news including media releases, photo and video galleries, fact sheets and publications.
- What predicts falls in Parkinson disease? Observations from the Parkinson's Foundation registry
- Intraoperative radiotherapy in the era of intensive neoadjuvant chemotherapy and chemoradiotherapy for pancreatic adenocarcinoma
- Phase II study of everolimus and octreotide LAR in patients with nonfunctioning gastrointestinal neuroendocrine tumors: The GETNE1003_EVERLAR study
- A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
- Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysis
PHARMACOLOGY
- Effects of clopidogrel with or without aspirin on the generation of extracellular vesicles in the microcirculation and in venous blood: A randomized placebo controlled trial
- Insufficient left ventricular unloading after extracorporeal membrane oxygenation
- Increased fracture risk with furosemide use in children with congenital heart disease
- How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?
- Alirocumab vs usual lipid-lowering care as add?on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM-DYSLIPIDEMIA randomized trial
CLINICAL PHARMACOLOGY
- Hepatectomy vs stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution
- A phase II study to prevent radiation-induced rectal injury with lovastatin
- Dermatofibrosarcoma Protuberans: A Retrospective Study of Clinicopathological Features and Related Akt/mTOR, STAT3, ERK, Cyclin D1, and PD-L1 Expression
- Conservative management following clinical complete response to neoadjuvant chemotherapy for muscle-invasive bladder cancer: Contemporary outcomes of a multi-institutional cohort study
- The potential of narrow band uvb to induce sustained durable complete remission off-therapy in stage I mycosis fungoides
ONCOLOGY